During the past decade, Krankenhaus St. Elisabeth gGmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Krankenhaus St. Elisabeth gGmbH" are "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials), "Intracranial Hemorrhage" (1 trials) and "Transient Ischemic Attack With Non-valvular Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Krankenhaus St. Elisabeth gGmbH" in a lesser frequency.

Most popular intervention types in "Krankenhaus St. Elisabeth gGmbH" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dabigatran Etexilate Oral Capsule [Pradaxa]" (1 trials), "Idarucizumab 2.5 GM/50 ML Intravenous Solution [PRAXBIND]" (1 trials) and "Vitamin K antagonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus St. Elisabeth gGmbH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus St. Elisabeth gGmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Krankenhaus St. Elisabeth gGmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus St. Elisabeth gGmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".